5 d. ago ExxonMobil to cut 2,000 jobs worldwide amid restructuring plans

A day after Calgary-based Imperial Oil announced plans to slash its workforce by 20 per cent, its parent company, ExxonMobil, also announced deep job cuts.

Other

2 w. ago Wegovy pill could deliver as much weight loss as the shot, trial shows

Novo Nordisk sought approval for its pill with the US Food and Drug Administration earlier this year

Other

2 w. ago Stocks Hold Near Record as Focus Turns to Fed Meet: Markets Wrap

Stocks hovered near record highs and the dollar steadied as a new week began, with investors focused on the Federal Reserve’s upcoming policy decision.

Economics

3 w. ago Novo and Orsted Made Denmark Rich. Are The Boom Times Now Over?

At their heights, Denmark’s corporate champions seemed untouchable. Novo Nordisk A/S, long known mostly as an insulin maker, was Europe’s most valuable company last year, after riding a surge of demand for Ozempic and Wegovy. That followed the success of Orsted A/S, the world’s largest offshore wind developer, which in 2021 was celebrating record valuations and racing to expand internationally as governments poured money into green energy.

Other

3 w. ago Ozempic, Wegovy makers Novo Nordisk announce 9K layoffs in restructuring

Ozempic and Wegovy maker Novo Nordisk says it will layoff about 9,000 employees of its global workforce as it restructures in an attempt to fend off competition.

Other

3 w. ago Novo Nordisk, maker of obesity drug Wegovy, to cut 9,000 jobs to sharpen focus, meet competition

FRANKFURT, Germany (AP) — Danish pharmaceutical company Novo Nordisk, maker of weight-loss drug Wegovy, said Wednesday it would cut 9,000 jobs, 5,000 of them in Denmark, in order to strengthen the company’s focus on growth opportunities in obesity and diabetes medications. The restructuring, which would eliminate 11% of the company’s workforce, aimed to reduce organizational […]

Other

last month WHO adds Ozempic and Mounjaro to its list of essential medicines

(Bloomberg) — The World Health Organization added Novo Nordisk A/S’s Ozempic and Eli Lilly & Co.’s Mounjaro to its list of essential medicines, a step that may expand access to the drugs around the world. The recommendation applies to a range of GLP-1 drugs that also includes Lilly’s older medicine Trulicity and Novo’s Victoza, the […]

Other